Javascript must be enabled to continue!
Common and emerging infectious causes of hematological malignancies in the young
View through CrossRef
Comparative epidemiological studies have for a long time suggested a link (or links) between infectious agents and hematological malignancies in the young. Identification of Epstein‐Barr virus (EBV) as the major cause of specific subtypes of Burkitt's lymphoma and Hodgkin's disease 20 and 10 years ago, respectively, and the recent involvement of human T‐cell leukemia virus in non‐Hodgkin's lymphomas of the T‐cell lineage in young adults in Jamaica have given further credit to early presumptions that these diseases have an infectious etiology. The spectrum of possibly involved viruses: old, EBV, and new, herpesviruses 6, 7 and 8, and unknown retroviruses – as well as the list of partially or totally unresolved disease entities: Hodgkin's disease in adolescents, non‐Hodgkin's lymphomas in the immunocompromised, and acute lymphocytic leukemia – is rapidly expanding. Both direct and indirect transforming effects of the above‐mentioned viruses are being rapidly disclosed. However, the complex interaction between the different viruses and other causes of hematological malignancies in the young guarantees that many things remain to be discovered also in the future.
Title: Common and emerging infectious causes of hematological malignancies in the young
Description:
Comparative epidemiological studies have for a long time suggested a link (or links) between infectious agents and hematological malignancies in the young.
Identification of Epstein‐Barr virus (EBV) as the major cause of specific subtypes of Burkitt's lymphoma and Hodgkin's disease 20 and 10 years ago, respectively, and the recent involvement of human T‐cell leukemia virus in non‐Hodgkin's lymphomas of the T‐cell lineage in young adults in Jamaica have given further credit to early presumptions that these diseases have an infectious etiology.
The spectrum of possibly involved viruses: old, EBV, and new, herpesviruses 6, 7 and 8, and unknown retroviruses – as well as the list of partially or totally unresolved disease entities: Hodgkin's disease in adolescents, non‐Hodgkin's lymphomas in the immunocompromised, and acute lymphocytic leukemia – is rapidly expanding.
Both direct and indirect transforming effects of the above‐mentioned viruses are being rapidly disclosed.
However, the complex interaction between the different viruses and other causes of hematological malignancies in the young guarantees that many things remain to be discovered also in the future.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Correlation Hematological Malignancies in the Hadhramout Sector Pattern and Distribution
Correlation Hematological Malignancies in the Hadhramout Sector Pattern and Distribution
Objective: To study the pattern and distribution of hematological cancers in Hadhramout sector-Yemen and compare with the findings elsewhere in the country and worldwide. Methods: ...
Spectrum of benign and malignant hematological diseases diagnosed in Quetta on bone marrow aspiration.
Spectrum of benign and malignant hematological diseases diagnosed in Quetta on bone marrow aspiration.
Objectives: Bone marrow aspiration is a diagnostic test for various hematological disorders. Present study was designed to determine the percentages and frequency of benign and mal...
Parthenolide: pioneering new frontiers in hematological malignancies
Parthenolide: pioneering new frontiers in hematological malignancies
Hematological malignancies are the fifth most prevalent cancer category in developed countries, presenting significant treatment challenges. The side effects of chemotherapy and it...
Laboratory Evaluation of Primary Immunodeficiencies from Secondary Immunodeficiencies in the Context of Hematological Malignancies: Review
Laboratory Evaluation of Primary Immunodeficiencies from Secondary Immunodeficiencies in the Context of Hematological Malignancies: Review
Background: Primary immunodeficiencies (PIDs) represent a diverse group of congenital disorders characterized by defects in the immune system. Distinguishing PIDs from secondary im...
Autoimmunity Checkpoints As Therapeutic Targets in B-Cell Malignancies
Autoimmunity Checkpoints As Therapeutic Targets in B-Cell Malignancies
Abstract
Concept. Targeted therapy of cancer typically focuses on inhibitors (e.g. tyrosine kinase inhibitors) that suppress oncogenic signaling below a minimum thre...
Hematological reference intervals among full-term newborns in Ethiopia: a cross-sectional study
Hematological reference intervals among full-term newborns in Ethiopia: a cross-sectional study
Abstract
Background: Hematological reference intervals are used for medical decision tools for interpretation of numerical test results. Establishing of hematological inter...
Emerging Metabolic Targets in the Therapy of Hematological Malignancies
Emerging Metabolic Targets in the Therapy of Hematological Malignancies
During the last decade, the development of anticancer therapies has focused on targeting neoplastic-related metabolism. Cancer cells display a variety of changes in their metabolis...

